NAYA Biosciences, Inc. Common Stock (NAYA)

• Market cap: $1.39M
• 1 day: 0.06%
• 5 days: -16.22%
• 1 month: -28.16%
• 3 months: -61.82%
• 6 months: -57.25%
• Year to date: -63.10%
• 1 year: -72.57%
• 5 years: -99.49%
• 10 years: -99.49%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: NAYA Biosciences operates a healthcare services fertility business as well as expand its focus to the development of first-in-class clinical-stage assets in oncology and autoimmune diseases.

Employees: 30

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

4.7% less ownership

Funds ownership: 7.0% [Q3] → 2.31% (-4.7%) [Q4]

33% less funds holding

Funds holding: 12 [Q3] → 8 (-4) [Q4]

57% less capital invested

Capital invested by funds: $194K [Q3] → $83.8K (-$111K) [Q4]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2 545% upside
• Avg. target: $2 545% upside
• High target: $2 545% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Jason McCarthy 18% 1-year accuracy 6 / 34 met price target

545% upside $2

Buy Upgraded

23 Jan 2025